Dr. Sergio Traversa
Chief Executive Officer
Replay available
Relmada Therapeutics, Inc. (RLMD) Q3 2025 Earnings Call
Relmada Therapeutics, Inc. (NASDAQ: RLMD) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Ritchie
LifeSci Advisors
Magid Shenouda
Chief Financial Officer
Dr. Raj Pruthi
Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Relmada Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.679 Good afternoon and welcome to Ramada Therapeutics' third quarter 2025 earnings 00:00:05.679 -- 00:00:07.722 conference call. 00:00:07.722 -- 00:00:11.968 At this time, all participants are in a listen-only mode. 00:00:11.968 -- 00:00:16.494 After the prepared remarks, we will conduct a question and answer session. 00:00:16.494 -- 00:00:21.459 To ask a question, please press star and 1. 00:00:21.622 -- 00:00:27.370 As a reminder, this conference call is being recorded and will be available for replay 00:00:27.370 -- 00:00:30.111 on the Ramada website. 00:00:30.946 -- 00:00:35.634 I would now like to turn the call over to Brian Ritchie of LifeSci Advisors. 00:00:35.634 -- 00:00:38.095 Please go ahead. 00:00:39.601 -- 00:00:43.026 Good day, everyone, and thank you for joining us today. 00:00:43.026 -- 00:00:48.235 This afternoon, RoMata issued a press release providing a business update 00:00:48.235 -- 00:00:54.959 and outlining its financial results for the three months ended September 30th, 2025. 00:00:54.959 -- 00:01:00.103 Please note that certain information discussed on the call today is covered under 00:01:00.103 -- 00:01:05.628 the safe harbor provision of the Private Securities Litigation Reform Act. 00:01:05.628 -- 00:01:10.693 We caution listeners that during this call, Ramada's management team will be making 00:01:10.693 -- 00:01:13.255 forward-looking statements. 00:01:13.255 -- 00:01:18.279 Actual results could differ materially from those stated or implied 00:01:18.279 -- 00:01:22.983 by these forward-looking statements due to risks and uncertainties associated with the 00:01:22.983 -- 00:01:27.786 company's business. These forward-looking statements are qualified by the cautionary 00:01:27.786 -- 00:01:32.851 statement...